Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $3,235.9M | $3,372.1M | $1,716.8M | $3,606.3M | $4,880.7M | $5,745.8M | $4,626.2M | $4,728.0M | $5,963.0M | $2,576.0M | $2,284.0M | $4,423.0M | $1,400.0M | $477.0M | $2,368.0M | $3,687.0M | $4,495.0M | $7,071.0M | $6,933.0M | $5,723.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Abbott Laboratories's last 12-month Net Income is $5,767.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Abbott Laboratories's Net Income growth was 11.7%. The average annual Net Income growth rates for Abbott Laboratories have been 0.2% over the past three years, 11.9% over the past five years.
Over the last year, Abbott Laboratories's Net Income growth was 11.7%, which is higher than industry growth of (0.2%). It indicates that Abbott Laboratories's Net Income growth is Good.